Dr James A. Bristol

Dr Bristol’s career in drug discovery research and development spans over 32 years and includes senior positions at Schering-Plough, Parke-Davis, and Pfizer. Most recently, he held the position of Senior Vice President, Worldwide Drug Discove…

Read more

Dr Chris Reilly

Dr Reilly was Global Vice President, Discovery Strategy and Performance and Head of Project Evaluation at AstraZeneca from 2005 to 2011. He was also responsible for developing AZ’s research strategy, business plan and performance improvement a…

Read more

Dr Phillip Hawkins

Dr Hawkins and Dr Stephens lead a team at the (BBSRC-sponsored) Babraham Institute in Cambridge. They have made world-leading contributions to the understanding of PI3 Kinases and neutrophils for over 20 years. Some of their recent work has focused on understanding the role of the p110β and p110δ isoforms in inflammatory responses.

Dr Len Stephens

Dr Stephens and Dr Hawkins lead a team at the (BBSRC-sponsored) Babraham Institute in Cambridge. They have made world-leading contributions to the understanding of PI3 Kinases and neutrophils for over 20 years. Some of their recent work has focused on understanding the role of the p110β and p110δ isoforms in inflammatory responses.

Professor Bart Vanhaesebroeck

Prof. Vanhaesebroeck is an expert in the biology of the isoforms of PI3K, and their involvement in diseases such as cancer and inflammation. He discovered the p110δ isoform of PI3K and has assisted in several PI3K drug development programs with…

Read more

Professor Patrick Matthias

Professor Matthias studies the biology of Histone Deacetylases, and his laboratory has made major contributions to understanding the function of several HDACs, in particular HDAC6, HDAC1 and HDAC2. Some of his current work has contributed to de…

Read more

Dr Paul Rennert

Dr Rennert is a top-tier Biotechnology Executive with strong strategic and leadership experience gained during an extensive career in the biotechnology industry. An immunologist, he spent nine years in Molecular Biology and Immunology at Replig…

Read more

Dr Klaus Okkenhaug

Dr Okkenhaug obtained his BSc in Biochemistry from the University of Victoria and his PhD in Immunology from the University of Toronto, where he studied CD28 signalling. He subsequently joined Bart Vanhaesebroeck's group in 1999, working on the…

Read more

Professor Jonathan Backer

Professor Backer serves as a Director of Belfer Institute for Advanced Biomedical Studies and Professor in the Department of Biochemistry at the Albert Einstein College of Medicine in New York. His research is focused on the biology of the PI3K …

Read more

Professor Jeffrey Evans

Professor Evans is Professor of Translational Cancer Research and Director of the Institute of Cancer Sciences, University of Glasgow. He is also Honorary Consultant in Medical Oncology at the Beatson West of Scotland Cancer Centre, Glasgow, Gr…

Read more

Dr Richard Groves

Dr Groves is a Consultant Dermatologist with a particular interest in complex medical dermatology. He runs a tertiary clinical and diagnostic service for patients with immunologically mediated skin diseases based at the St. John's Institute of D…

Read more